Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 08/31/08
Due: 08/31/09
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension | NCT00779181 | Addrenex Pharmaceuticals, Inc. | user2@example.com | None | 2008-10-31 | 2008-12-31 | 2009-12-31 | - | - | 2025-07-14 |
| CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD | NCT00641329 | Addrenex Pharmaceuticals, Inc. | user2@example.com | None | 2008-02-29 | 2009-02-28 | 2010-02-28 | - | - | 2025-07-14 |
| Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) | NCT00556959 | Addrenex Pharmaceuticals, Inc. | user2@example.com | None | 2007-10-31 | 2008-08-31 | 2009-08-31 | - | - | 2025-07-14 |